Blog

Vineti Completes $33.5 Million in Series B Financing to Accelerate Patient Access to Cell and Gene Therapies – GlobeNewswire (press release)


FierceBiotech

Vineti Completes $33.5 Million in Series B Financing to Accelerate Patient Access to Cell and Gene Therapies
GlobeNewswire (press release)
Vineti's configurable, cloud-based software platform improves cell and gene therapy product performance, promotes regulatory compliance, and enables faster, safer, broader access for patients. The platform automates, orchestrates, and simplifies the
Vineti bags $34M to support CAR-T logisticsFierceBiotech



all 2 news articles »

2018-04-16 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.